New hope for Tough-to-Treat asthma: targeting hidden autoimmunity

This study looked at whether the drug dupilumab could help control severe asthma by reducing autoimmune activity in the airways. It involved 30 patients with severe asthma who weren't getting enough relief from standard steroid treatments. Researchers measured markers of autoimmunity before and after four months of dupilumab treatment to see if blocking specific inflammatory signals (IL-13/IL-4) provided a new way to manage this difficult condition.